| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |